ATE120734T1 - Glyzerin-derivat und dessen pharmazeutische verwendung. - Google Patents

Glyzerin-derivat und dessen pharmazeutische verwendung.

Info

Publication number
ATE120734T1
ATE120734T1 AT89112204T AT89112204T ATE120734T1 AT E120734 T1 ATE120734 T1 AT E120734T1 AT 89112204 T AT89112204 T AT 89112204T AT 89112204 T AT89112204 T AT 89112204T AT E120734 T1 ATE120734 T1 AT E120734T1
Authority
AT
Austria
Prior art keywords
pharmaceutical use
glycerine derivative
derivative
glycerine
chem
Prior art date
Application number
AT89112204T
Other languages
English (en)
Inventor
Kazuo Okano
Osamu Asano
Naoyuki Shimomura
Tetsuya Kawahara
Shinya Abe
Shuhei Miyazawa
Mitsuaki Miyamoto
Hiroyuki Yoshimura
Koukichi Harada
Junsaku Nagaoka
Tsutomu Kawata
Tsutomu Yoshimura
Hiromasa Suzuki
Shigeru Souda
Yoshimasa Machida
Kouichi Katayama
Isao Yamatsu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE120734T1 publication Critical patent/ATE120734T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT89112204T 1988-07-04 1989-07-04 Glyzerin-derivat und dessen pharmazeutische verwendung. ATE120734T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16638688 1988-07-04

Publications (1)

Publication Number Publication Date
ATE120734T1 true ATE120734T1 (de) 1995-04-15

Family

ID=15830457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89112204T ATE120734T1 (de) 1988-07-04 1989-07-04 Glyzerin-derivat und dessen pharmazeutische verwendung.

Country Status (20)

Country Link
US (1) US5037827A (de)
EP (1) EP0353474B1 (de)
JP (1) JP2766319B2 (de)
KR (1) KR910006127B1 (de)
CN (1) CN1041920C (de)
AT (1) ATE120734T1 (de)
AU (1) AU621634B2 (de)
CA (1) CA1334753C (de)
DD (1) DD297814A5 (de)
DE (1) DE68922035T2 (de)
DK (1) DK329189A (de)
ES (1) ES2070148T3 (de)
FI (1) FI97883C (de)
GR (1) GR3015704T3 (de)
HU (2) HUT62855A (de)
NO (1) NO177495C (de)
NZ (1) NZ229789A (de)
PH (1) PH26045A (de)
PT (1) PT91051B (de)
RU (1) RU2040521C1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5700817A (en) * 1992-06-30 1997-12-23 Pohang Iron & Steel Co., Ltd. Cyclic lipid derivatives as potent PAF antagonists
JP3298883B2 (ja) * 1992-06-30 2002-07-08 ポハン アイアン アンド スチール カンパニー リミテッド 強力なｐａｆ拮抗剤としての新規な環式脂質誘導体
JPH07285866A (ja) * 1994-02-22 1995-10-31 Eisai Co Ltd 臓器障害予防・治療・改善剤
US5854279A (en) * 1996-06-04 1998-12-29 Eisai Co., Ltd Therapeutic agent for dermatosis
US6177067B1 (en) 1996-08-09 2001-01-23 Shiseido Company, Ltd. Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014778B1 (de) * 1979-02-19 1983-05-18 BBC Aktiengesellschaft Brown, Boveri & Cie. Zweistüfiges Abgasturboladeraggregat
ZA8410014B (en) * 1983-12-30 1985-08-28 Hoffmann La Roche Glycerol derivatives
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
DE3586746T2 (de) * 1984-04-03 1993-03-04 Takeda Chemical Industries Ltd Lipidderivate, ihre produktion und verwendung.
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives
JPH0815643B2 (ja) * 1988-05-19 1996-02-21 新日本製鐵株式会社 幅可変薄スラブ連続鋳造機の湯面レベル制御方法

Also Published As

Publication number Publication date
AU621634B2 (en) 1992-03-19
PT91051B (pt) 1995-06-30
HU9202211D0 (en) 1992-12-28
PT91051A (pt) 1990-02-08
US5037827A (en) 1991-08-06
ES2070148T3 (es) 1995-06-01
FI97883B (fi) 1996-11-29
KR900001654A (ko) 1990-02-27
DE68922035D1 (de) 1995-05-11
FI893099A (fi) 1990-01-05
EP0353474A2 (de) 1990-02-07
GR3015704T3 (en) 1995-07-31
AU3721389A (en) 1990-01-04
CN1039414A (zh) 1990-02-07
HUT62855A (en) 1993-06-28
NO892743L (no) 1990-01-05
CN1041920C (zh) 1999-02-03
CA1334753C (en) 1995-03-14
KR910006127B1 (ko) 1991-08-13
EP0353474A3 (de) 1991-03-27
FI893099A0 (fi) 1989-06-26
JPH02131467A (ja) 1990-05-21
DE68922035T2 (de) 1995-09-14
NZ229789A (en) 1991-04-26
HU208119B (en) 1993-08-30
NO177495C (no) 1995-09-27
PH26045A (en) 1992-01-29
HUT52478A (en) 1990-07-28
DK329189D0 (da) 1989-07-03
DD297814A5 (de) 1992-01-23
EP0353474B1 (de) 1995-04-05
JP2766319B2 (ja) 1998-06-18
FI97883C (fi) 1997-03-10
RU2040521C1 (ru) 1995-07-25
NO892743D0 (no) 1989-07-03
DK329189A (da) 1990-01-05
NO177495B (no) 1995-06-19

Similar Documents

Publication Publication Date Title
KR900009625A (ko) 피리미딘류 및 그의 약리학적으로 허용되는 염류 및 그 용도
CY1109869T1 (el) Παραγωγη πεπτιδιων και φαρμακευτικα αποδεκτων αλατων τους, τροποι συνθεσης, χρησης και φαρμακευτικης συνθεσης
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
FI954007A (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
FR2630328B1 (fr) Derive de l'histamine, sa preparation et son application en therapeutique
DE69011913D1 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung.
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
DK199789A (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ATE120734T1 (de) Glyzerin-derivat und dessen pharmazeutische verwendung.
DE69628543D1 (de) Indolderivate und ihre medizinische verwendung
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
ATE144515T1 (de) Pyridylthiazolidinsäureamid-derivate, ihre herstellung und therapeutische verwendungen
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
DE68906437D1 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
SE9000288D0 (sv) New use
FI935388A0 (fi) Menetelmä lääkeaineena käyttökelpoisen bentsimidatsolidipyridiniumjohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee